Center for Digital Cardiovascular Innovations, Division of Cardiovascular Medicine, University of Miami Miller School of Medicine, Miami, Florida, USA; Cardiovascular Biology and Biomechanics Laboratory (CBBL), Cardiovascular Division, University of Nebraska Medical Center, Omaha, Nebraska, USA.
California Medical Innovations Institute, San Diego, California, USA.
JACC Cardiovasc Interv. 2023 Oct 23;16(20):2479-2497. doi: 10.1016/j.jcin.2023.07.022.
Artificial intelligence, computational simulations, and extended reality, among other 21st century computational technologies, are changing the health care system. To collectively highlight the most recent advances and benefits of artificial intelligence, computational simulations, and extended reality in cardiovascular therapies, we coined the abbreviation AISER. The review particularly focuses on the following applications of AISER: 1) preprocedural planning and clinical decision making; 2) virtual clinical trials, and cardiovascular device research, development, and regulatory approval; and 3) education and training of interventional health care professionals and medical technology innovators. We also discuss the obstacles and constraints associated with the application of AISER technologies, as well as the proposed solutions. Interventional health care professionals, computer scientists, biomedical engineers, experts in bioinformatics and visualization, the device industry, ethics committees, and regulatory agencies are expected to streamline the use of AISER technologies in cardiovascular interventions and medicine in general.
人工智能、计算模拟和扩展现实等 21 世纪计算技术正在改变医疗保健系统。为了集中强调人工智能、计算模拟和扩展现实在心血管治疗方面的最新进展和益处,我们创造了缩写词 AISER。本综述特别关注 AISER 的以下应用:1)术前规划和临床决策;2)虚拟临床试验以及心血管设备的研究、开发和监管审批;3)介入性医疗保健专业人员和医疗技术创新者的教育和培训。我们还讨论了与 AISER 技术应用相关的障碍和限制,以及提出的解决方案。介入性医疗保健专业人员、计算机科学家、生物医学工程师、生物信息学和可视化专家、器械行业、伦理委员会和监管机构有望简化 AISER 技术在心血管介入和一般医学中的应用。